{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:59:08Z","timestamp":1781614748900,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate intra-host evolution of SARS-CoV-2 in critically ill patients with severe lung failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between November 2020 to December 2022, respiratory samples were collected from 41 mechanically ventilated patients at the intensive care unit of University Hospital Regensburg, Germany, including 16 on extracorporeal membrane oxygenation (ECMO). Paired initial and follow-up samples were obtained at a median interval of 15 days (range: 6\u201342) and analyzed using next-generation sequencing. Amino acid substitutions in the viral genome were correlated with clinical, virological, immunological, and therapeutic markers using binary logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventeen of 41 patients (41%) developed amino acid substitutions in non-structural proteins (nsp2, 3, 4, 10, 12, 14, and 15), ORF3a, ORF8, and structural proteins (spike and nucleocapsid). Among 27 identified mutations, 21 were single nucleotide polymorphisms, and 6 were nucleotide deletions (3 single, 3 multiple). Notably, 20 mutations (74.1%) represented reversions to the ancestral Wuhan-1 sequence, including eight at position 323 in nsp12. Mutation occurrence was significantly associated with younger age, prolonged ICU stay, ECMO therapy, catecholamine use, thrombotic events, extended viral replication, and Delta variant infection (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), whereas Remdesivir therapy showed a negative association. Multivariate analysis confirmed younger age, prolonged replication, and ECMO as independent predictors of intra-host viral evolution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intra-host SARS-CoV-2 evolution in critically ill patients is driven by disease severity and prolonged viral replication. Frequent reversions to the ancestral sequence suggest selective pressure favoring wildtype variants in inflamed and hypoxic lung areas \u2013 a process attenuated by the administration of Remdesivir.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-025-02650-5","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:09:50Z","timestamp":1759939790000},"page":"225-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Back to the wildtype: SARS-CoV-2 evolution in critically ill patients with severe lung failure"],"prefix":"10.1007","volume":"54","author":[{"given":"Tanja","family":"Kraft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara L.","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hiergeist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen J.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hanses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schneckenpointner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Lubnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Lunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hitzenbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Haehnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas-Michael","family":"Brosig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Poeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Salzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"4","key":"2650_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812\u2013. https:\/\/doi.org\/10.1016\/j.cell.2020.06.043. \u200927 e19.","journal-title":"Cell"},{"issue":"4","key":"2650_CR2","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.5808\/GI.2020.18.4.e44","volume":"18","author":"SK Biswas","year":"2020","unstructured":"Biswas SK, Mudi SR. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19. Genomics Inf. 2020;18(4):e44. https:\/\/doi.org\/10.5808\/GI.2020.18.4.e44.","journal-title":"Genomics Inf"},{"key":"2650_CR3","doi-asserted-by":"publisher","unstructured":"Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538). https:\/\/doi.org\/10.1126\/science.abg3055.","DOI":"10.1126\/science.abg3055"},{"issue":"7854","key":"2650_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","volume":"592","author":"H Tegally","year":"2021","unstructured":"Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592(7854):438\u201343. https:\/\/doi.org\/10.1038\/s41586-021-03402-9.","journal-title":"Nature"},{"issue":"6544","key":"2650_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.abh2644","volume":"372","author":"NR Faria","year":"2021","unstructured":"Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372(6544):815\u201321. https:\/\/doi.org\/10.1126\/science.abh2644.","journal-title":"Science"},{"issue":"13","key":"2650_CR6","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.cell.2021.04.025","volume":"184","author":"X Deng","year":"2021","unstructured":"Deng X, Garcia-Knight MA, Khalid MM, Servellita V, Wang C, Morris MK, et al. Transmission, infectivity, and neutralization of a Spike L452R SARS-CoV-2 variant. Cell. 2021;184(13):3426\u2013e378. https:\/\/doi.org\/10.1016\/j.cell.2021.04.025.","journal-title":"Cell"},{"issue":"7902","key":"2650_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","volume":"603","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann PJ, Iida S, Iwatsuki-Horimoto K, Maemura T, Kiso M, Scheaffer SM, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 2022;603(7902):687\u201392. https:\/\/doi.org\/10.1038\/s41586-022-04441-6.","journal-title":"Nature"},{"issue":"7853","key":"2650_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","volume":"592","author":"SA Kemp","year":"2021","unstructured":"Kemp SA, Collier DA, Datir RP, Ferreira I, Gayed S, Jahun A, et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592(7853):277\u201382. https:\/\/doi.org\/10.1038\/s41586-021-03291-y.","journal-title":"Nature"},{"key":"2650_CR9","doi-asserted-by":"publisher","first-page":"100210","DOI":"10.1016\/j.clinpr.2022.100210","volume":"16","author":"D Hettle","year":"2022","unstructured":"Hettle D, Hutchings S, Muir P, consortium Moran E. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: retrospective cohort study and literature review. Clin Infect Pract. 2022;16:100210. https:\/\/doi.org\/10.1016\/j.clinpr.2022.100210.","journal-title":"Clin Infect Pract"},{"key":"2650_CR10","doi-asserted-by":"publisher","first-page":"933983","DOI":"10.3389\/fmicb.2022.933983","volume":"13","author":"NM Markarian","year":"2022","unstructured":"Markarian NM, Galli G, Patel D, Hemmings M, Nagpal P, Berghuis AM, et al. Identifying markers of emerging SARS-CoV-2 variants in patients with secondary immunodeficiency. Front Microbiol. 2022;13:933983. https:\/\/doi.org\/10.3389\/fmicb.2022.933983.","journal-title":"Front Microbiol"},{"issue":"2","key":"2650_CR11","doi-asserted-by":"publisher","first-page":"veac050","DOI":"10.1093\/ve\/veac050","volume":"8","author":"SAJ Wilkinson","year":"2022","unstructured":"Wilkinson SAJ, Richter A, Casey A, Osman H, Mirza JD, Stockton J, et al. Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evol. 2022;8(2):veac050. https:\/\/doi.org\/10.1093\/ve\/veac050.","journal-title":"Virus Evol"},{"issue":"8001","key":"2650_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41586-024-07029-4","volume":"626","author":"M Ghafari","year":"2024","unstructured":"Ghafari M, Hall M, Golubchik T, Ayoubkhani D, House T, MacIntyre-Cockett G, et al. Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature. 2024;626(8001):1094\u2013101. https:\/\/doi.org\/10.1038\/s41586-024-07029-4.","journal-title":"Nature"},{"issue":"24","key":"2650_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.15585\/mmwr.mm6924e2","volume":"69","author":"EK Stokes","year":"2020","unstructured":"Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai Felix S, et al. Coronavirus disease 2019 case Surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759\u201365. https:\/\/doi.org\/10.15585\/mmwr.mm6924e2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"2650_CR14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345\u201355. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3539.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2650_CR15","doi-asserted-by":"publisher","first-page":"e0280502","DOI":"10.1371\/journal.pone.0280502","volume":"18","author":"B Kieninger","year":"2023","unstructured":"Kieninger B, Kilger M, Foltan M, Gruber M, Lunz D, Dienemann T, et al. Prognostic factors for favorable outcomes after veno-venous extracorporeal membrane oxygenation in critical care patients with COVID-19. PLoS ONE. 2023;18(1):e0280502. https:\/\/doi.org\/10.1371\/journal.pone.0280502.","journal-title":"PLoS ONE"},{"key":"2650_CR16","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1053\/j.jvca.2021.11.006","volume":"36","author":"P Bertini","year":"2022","unstructured":"Bertini P, Guarracino F, Falcone M, Nardelli P, Landoni G, Nocci M, et al. ECMO in COVID-19 patients: A systematic review and Meta-analysis. J Cardiothorac Vasc Anesth. 2022;36:2700\u20136. https:\/\/doi.org\/10.1053\/j.jvca.2021.11.006. (8 Pt A).","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"2650_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S2213-2600(22)00438-6","volume":"11","author":"M Schmidt","year":"2023","unstructured":"Schmidt M, Hajage D, Landoll M, Pequignot B, Langouet E, Amalric M, et al. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med. 2023;11(2):163\u201375. https:\/\/doi.org\/10.1016\/S2213-2600(22)00438-6.","journal-title":"Lancet Respir Med"},{"key":"2650_CR18","doi-asserted-by":"publisher","first-page":"966236","DOI":"10.3389\/fimmu.2022.966236","volume":"13","author":"CL Magnus","year":"2022","unstructured":"Magnus CL, Hiergeist A, Schuster P, Rohrhofer A, Medenbach J, Gessner A, et al. Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of Sotrovimab. Front Immunol. 2022;13:966236. https:\/\/doi.org\/10.3389\/fimmu.2022.966236.","journal-title":"Front Immunol"},{"issue":"4","key":"2650_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357\u20139. https:\/\/doi.org\/10.1038\/nmeth.1923.","journal-title":"Nat Methods"},{"issue":"22","key":"2650_CR20","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm A, Aw PP, Bertrand D, Yeo GH, Ong SH, Wong CH, et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for Uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 2012;40(22):11189\u2013201. https:\/\/doi.org\/10.1093\/nar\/gks918.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2650_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, snpeff: SNPs in the genome of drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6(2):80\u201392. https:\/\/doi.org\/10.4161\/fly.19695.","journal-title":"Fly (Austin)"},{"key":"2650_CR22","doi-asserted-by":"publisher","first-page":"105323","DOI":"10.1016\/j.jcv.2022.105323","volume":"157","author":"PL Tzou","year":"2022","unstructured":"Tzou PL, Tao K, Sahoo MK, Kosakovsky Pond SL, Pinsky BA, Shafer RW. Sierra SARS-CoV-2 sequence and antiviral resistance analysis program. J Clin Virol. 2022;157:105323. https:\/\/doi.org\/10.1016\/j.jcv.2022.105323.","journal-title":"J Clin Virol"},{"issue":"49","key":"2650_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","volume":"3","author":"S Khare","year":"2021","unstructured":"Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, et al. GISAID\u2019s role in pandemic response. China CDC Wkly. 2021;3(49):1049\u201351. https:\/\/doi.org\/10.46234\/ccdcw2021.255.","journal-title":"China CDC Wkly"},{"issue":"1","key":"2650_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s15010-020-01503-7","volume":"49","author":"D Peterhoff","year":"2021","unstructured":"Peterhoff D, Gluck V, Vogel M, Schuster P, Schutz A, Neubert P, et al. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization. Infection. 2021;49(1):75\u201382. https:\/\/doi.org\/10.1007\/s15010-020-01503-7.","journal-title":"Infection"},{"issue":"6","key":"2650_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0267659121995997","volume":"36","author":"E Dreier","year":"2021","unstructured":"Dreier E, Malfertheiner MV, Dienemann T, Fisser C, Foltan M, Geismann F, et al. ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion. 2021;36(6):582\u201391. https:\/\/doi.org\/10.1177\/0267659121995997.","journal-title":"Perfusion"},{"issue":"4","key":"2650_CR26","doi-asserted-by":"publisher","first-page":"e0298342","DOI":"10.1371\/journal.pone.0298342","volume":"19","author":"C Wiest","year":"2024","unstructured":"Wiest C, Philipp A, Foltan M, Geismann F, Schneckenpointer R, Baumgartner S, et al. Refractory circulatory failure in COVID-19 patients treated with veno-arterial ECMO a retrospective single-center experience. PLoS ONE. 2024;19(4):e0298342. https:\/\/doi.org\/10.1371\/journal.pone.0298342.","journal-title":"PLoS ONE"},{"issue":"8","key":"2650_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2213-2600(21)00096-5","volume":"9","author":"G Lebreton","year":"2021","unstructured":"Lebreton G, Schmidt M, Ponnaiah M, Folliguet T, Para M, Guihaire J, et al. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in greater Paris, france: a multicentre cohort study. Lancet Respir Med. 2021;9(8):851\u201362. https:\/\/doi.org\/10.1016\/S2213-2600(21)00096-5.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"2650_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/EJA.0000000000001670","volume":"39","author":"B Friedrichson","year":"2022","unstructured":"Friedrichson B, Kloka JA, Neef V, Mutlak H, Old O, Zacharowski K, et al. Extracorporeal membrane oxygenation in coronavirus disease 2019: A nationwide cohort analysis of 4279 runs from Germany. Eur J Anaesthesiol. 2022;39(5):445\u201351. https:\/\/doi.org\/10.1097\/EJA.0000000000001670.","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"2650_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3238\/arztebl.m2022.0354","volume":"120","author":"C Wiest","year":"2023","unstructured":"Wiest C, Philipp A, Lunz D, Steinmann JF, Eissnert C, Kees M, et al. The long-term support of COVID-19 patients with veno-venous extracorporeal membrane oxygenation. Dtsch Arztebl Int. 2023;120(4):56\u20137. https:\/\/doi.org\/10.3238\/arztebl.m2022.0354.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2650_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12890-023-02836-3","volume":"24","author":"JM de Walque","year":"2024","unstructured":"de Walque JM, de Terwangne C, Jungers R, Pierard S, Beauloye C, Laarbaui F, et al. Potential for recovery after extremely prolonged VV-ECMO support in well-selected severe COVID-19 patients: a retrospective cohort study. BMC Pulm Med. 2024;24(1):19. https:\/\/doi.org\/10.1186\/s12890-023-02836-3.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"2650_CR31","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/dc20-0576","volume":"43","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392\u20138. https:\/\/doi.org\/10.2337\/dc20-0576.","journal-title":"Diabetes Care"},{"issue":"13","key":"2650_CR32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-Infected pneumonia. N Engl J Med. 2020;382(13):1199\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa2001316.","journal-title":"N Engl J Med"},{"key":"2650_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u20137. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.013.","journal-title":"Thromb Res"},{"issue":"4","key":"2650_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844\u20137. https:\/\/doi.org\/10.1111\/jth.14768.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2650_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/jmv.25871","volume":"92","author":"C Tan","year":"2020","unstructured":"Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856\u201362. https:\/\/doi.org\/10.1002\/jmv.25871.","journal-title":"J Med Virol"},{"issue":"18","key":"2650_CR36","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032.","journal-title":"N Engl J Med"},{"key":"2650_CR37","doi-asserted-by":"publisher","unstructured":"Lawrence Panchali MJ, Kim CM, Seo JW, Kim DY, Yun NR, Kim DM. SARS-CoV-2 rnaemia and disease severity in COVID-19 patients. Viruses. 2023;15(7). https:\/\/doi.org\/10.3390\/v15071560.","DOI":"10.3390\/v15071560"},{"issue":"3","key":"2650_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jmv.27416","volume":"94","author":"A Alam","year":"2022","unstructured":"Alam A, Islam OK, Hasan MS, Islam MR, Mahmud S, Al-Emran HM, et al. Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: an in Silico based hypothetical model. J Med Virol. 2022;94(3):1035\u201349. https:\/\/doi.org\/10.1002\/jmv.27416.","journal-title":"J Med Virol"},{"key":"2650_CR39","doi-asserted-by":"publisher","unstructured":"Ravi R, Swaminathan V, Yadav A, Arya S, Pandey H. SARS-CoV-2 variants of concern and variations within their genome architecture: does nucleotide distribution and mutation rate alter the functionality and evolution of the virus? Viruses. 2022;14(11). https:\/\/doi.org\/10.3390\/v14112499.","DOI":"10.3390\/v14112499"},{"issue":"1","key":"2650_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12967-020-02344-6","volume":"18","author":"M Pachetti","year":"2020","unstructured":"Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, Storici P, et al. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. J Transl Med. 2020;18(1):179. https:\/\/doi.org\/10.1186\/s12967-020-02344-6.","journal-title":"J Transl Med"},{"issue":"9","key":"2650_CR41","doi-asserted-by":"publisher","first-page":"113077","DOI":"10.1016\/j.celrep.2023.113077","volume":"42","author":"SM Kim","year":"2023","unstructured":"Kim SM, Kim EH, Casel MAB, Kim YI, Sun R, Kwak MJ, et al. SARS-CoV-2 variants with NSP12 P323L\/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility. Cell Rep. 2023;42(9):113077. https:\/\/doi.org\/10.1016\/j.celrep.2023.113077.","journal-title":"Cell Rep"},{"issue":"8","key":"2650_CR42","doi-asserted-by":"publisher","first-page":"e07866","DOI":"10.1016\/j.heliyon.2021.e07866","volume":"7","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Kader SB, Rizvi SMS. Molecular characterization of SARS-CoV-2 from bangladesh: implications in genetic diversity, possible origin of the virus, and functional significance of the mutations. Heliyon. 2021;7(8):e07866. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07866.","journal-title":"Heliyon"},{"key":"2650_CR43","doi-asserted-by":"publisher","unstructured":"Mohammad A, Al-Mulla F, Wei DQ, Abubaker J. Remdesivir MD simulations suggest a more favourable binding to SARS-CoV-2 RNA dependent RNA polymerase mutant P323L than Wild-Type. Biomolecules. 2021;11(7). https:\/\/doi.org\/10.3390\/biom11070919.","DOI":"10.3390\/biom11070919"},{"key":"2650_CR44","doi-asserted-by":"publisher","unstructured":"Nagaraja M, Sireesha K, Srikar A, Sudheer Kumar K, Mohan A, Vengamma B, et al. Mutation analysis of SARS-CoV-2 variants isolated from symptomatic cases from Andhra Pradesh, India. Viruses. 2023;15(8). https:\/\/doi.org\/10.3390\/v15081656.","DOI":"10.3390\/v15081656"},{"key":"2650_CR45","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.compbiomed.2021.104654","volume":"135","author":"RY Aljindan","year":"2021","unstructured":"Aljindan RY, Al-Subaie AM, Al-Ohali AI, Kumar DT, Doss CG, Kamaraj B. Investigation of nonsynonymous mutations in the Spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular Docking and MM\/GBSA approach. Comput Biol Med. 2021;135:104654. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104654.","journal-title":"Comput Biol Med"},{"issue":"19","key":"2650_CR46","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - Final report. N Engl J Med. 2020;383(19):1813\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2007764.","journal-title":"N Engl J Med"},{"issue":"8","key":"2650_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RC Group","year":"2021","unstructured":"Group RC, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"key":"2650_CR48","doi-asserted-by":"publisher","first-page":"05009","DOI":"10.7189\/jogh.14.05009","volume":"14","author":"F Afroze","year":"2024","unstructured":"Afroze F, Begum MN, Ahmed T, El Arifeen S, Rahman MZ, Rahman AE, et al. Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh. J Glob Health. 2024;14:05009. https:\/\/doi.org\/10.7189\/jogh.14.05009.","journal-title":"J Glob Health"},{"key":"2650_CR49","doi-asserted-by":"publisher","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Br\u00fcnink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3):2000045. Erratum in: Euro Surveill. 2020;25(14). Erratum in: Euro Surveill. 2020;25(30). Erratum in: Euro Surveill. 2021;26(5). PMID: 31992387; PMCID: PMC6988269. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.3.2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"2650_CR50","doi-asserted-by":"publisher","unstructured":"Hitzenbichler F, Bauernfeind S, Salzberger B, Schmidt B, Wenzel JJ. Comparison of Throat Washings, Nasopharyngeal Swabsand Oropharyngeal Swabs for Detection of SARS-CoV-2. Viruses. 2021 Apr 10;13(4):653. PMID:33920072; PMCID: PMC8069237. https:\/\/doi.org\/10.3390\/v13040653","DOI":"10.3390\/v13040653"},{"key":"2650_CR51","doi-asserted-by":"publisher","unstructured":"Magnus CL, Hiergeist A, Schuster P, Rohrhofer A, Medenbach J, Gessner A, Peterhoff D, Schmidt B. Targeted escape ofSARS-CoV-2in vitro from monoclonal antibody S309, the precursor of sotrovimab. Front Immunol. 2022;24;13:966236. PMID: 36090991; PMCID: PMC9449809. https:\/\/doi.org\/10.3389\/fimmu.2022.966236","DOI":"10.3389\/fimmu.2022.966236"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02650-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:33:04Z","timestamp":1781613184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2650"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02650-5","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee at the Faculty for Medicine, University of Regensburg, Regensburg, Germany (Reference number 20-1785-101).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}